JUN 13, 2019 11:44 AM PDT

Proton Therapy May Reduce Second Cancer Risk More Than Other Radiation Types

WRITTEN BY: Julia Travers

A new study finds that proton beam radiation therapy (PBRT) might lead to a reduction in the risk for a second cancer, when compared to other types of contemporary radiation therapy. The researchers analyzed National Cancer Database (NCDB) data on adult and pediatric patients with cancer. It used the data to determine the second-cancer risk associated with three types of radiation therapy (RT):  PBRT, intensity-modulated radiation therapy (IMRT) and three-dimensional conformal radiation therapy (3DCRT). The therapies included were administered between 2004 and 2016 to patients of diverse ages, and those with metastatic disease were not included.

PBRT, credit: public domain

PBRT Study Design and Findings

Head and/or neck, breast, gastrointestinal, gynecologic, non–small cell lung, prostate, bone/soft tissue, lymphoma and brain/central nervous system tumors were included. The total number of patients whose data were analyzed was 450,373. The percentage of people who also received chemotherapy was higher in the 3DCRT group, at 48 percent, and lower in the IMRT and PBRT groups, which were at 38 and 17 percent, respectively. PBRT was used most with prostate tumors. Head and neck cancers were treated primarily with IMRT, and 3DCRT was utilized most often for breast cancers.

The crude absolute incidence rate of subsequent cancer diagnosis per 100 patient-years was 1.60 in the 3DCRT cohort, 1.55 in the IMRT cohort, and 0.44 in the PBRT cohort.

PBRT Study Conclusions and Limitations

“Patients most likely to benefit from PBRT may be [children] and young adults due to the potential for a long life expectancy and increased susceptibility to treatment-related malignancies,” Michael Xiang, M.D., Ph.D., of Stanford University, said.

Some of the study’s constraints were tied to the NCDB, which does not allow researchers to discern the location of a second cancer relative to an RT field. The database also does not account for risk factors like obesity or smoking, among other limitations.

To learn the basics of how proton therapy treats cancer, check out the video below.

Source: ASCO News

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech and conservation.
You May Also Like
JAN 17, 2020
Cancer
JAN 17, 2020
Scientists develop a single delivery immunotherapy threatment
Research published recently in Cell Stem Cell details the results from a new anticancer immunotherapy that uses invariant natural killer T (iNKT) cells. Th...
JAN 17, 2020
Cancer
JAN 17, 2020
New diagnostic tool for thyroid cancer
Thyroid cancer diagnoses have risen in the last thirty years from 6 per 100,000 to more than 14 per 100,000. That’s according to the Surveillance, Ep...
JAN 17, 2020
Cancer
JAN 17, 2020
Specific gut bacteria linked to bowel cancer
New research suggests that the presence of a certain kind of gut bacteria can increase the risk of bowel cancer by as much as 15%. The research is importan...
JAN 17, 2020
Genetics & Genomics
JAN 17, 2020
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
JAN 17, 2020
Genetics & Genomics
JAN 17, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 17, 2020
Cancer
JAN 17, 2020
Good news for patients with testicular cancer!
Good news for patients with testicular cancer! A new clinical trial has shown that using just half of the quantity of chemotherapy traditionally administer...
Loading Comments...